Want to see JAGX full AI Analyst Report?
Total Valuation
Jaguar Animal Health has a market cap or net worth of $1.69M. The enterprise value is $27.19M.
Market Cap$1.69M
Enterprise Value$27.19M
Share Statistics
Jaguar Animal Health has 603,134 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding603,134
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jaguar Animal Health’s return on equity (ROE) is 3.10 and return on invested capital (ROIC) is -180.03%.
Return on Equity (ROE)3.10
Return on Assets (ROA)-1.40
Return on Invested Capital (ROIC)-180.03%
Return on Capital Employed (ROCE)19.69
Revenue Per Employee234.92K
Profits Per Employee-313.76K
Employee Count49
Asset Turnover0.30
Inventory Turnover0.44
Valuation Ratios
The current PE Ratio of Jaguar Animal Health is ―. Jaguar Animal Health’s PEG ratio is 0.00049.
PE Ratio―
PS Ratio0.19
PB Ratio-0.13
Price to Fair Value-0.13
Price to FCF0.38
Price to Operating Cash Flow―
PEG Ratio0.00049
Income Statement
In the last 12 months, Jaguar Animal Health had revenue of 11.51M and earned -53.58M in profits. Earnings per share was -803.95.
Revenue11.51M
Gross Profit7.74M
Operating Income-45.91M
Pretax Income-54.00M
Net Income-53.58M
EBITDA-37.89M
Earnings Per Share (EPS)-803.95
Cash Flow
In the last 12 months, operating cash flow was -23.74M and capital expenditures -25.00K, giving a free cash flow of -23.77M billion.
Operating Cash Flow-23.74M
Free Cash Flow-23.77M
Free Cash Flow per Share-39.40
Dividends & Yields
Jaguar Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.37
52-Week Price Change-96.84%
50-Day Moving Average4.17
200-Day Moving Average31.24
Relative Strength Index (RSI)40.07
Average Volume (3m)109.63K
Important Dates
Jaguar Animal Health upcoming earnings date is Aug 19, 2026, TBA (Confirmed).
Last Earnings DateMay 20, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
Jaguar Animal Health as a current ratio of 0.50, with Debt / Equity ratio of ―
Current Ratio0.50
Quick Ratio0.29
Debt to Market Cap19.58
Net Debt to EBITDA-1.13
Interest Coverage Ratio685.19
Taxes
In the past 12 months, Jaguar Animal Health has paid -422.00K in taxes.
Income Tax-422.00K
Effective Tax Rate<0.01
Enterprise Valuation
Jaguar Animal Health EV to EBITDA ratio is -1.18, with an EV/FCF ratio of 7.76.
EV to Sales3.89
EV to EBITDA-1.18
EV to Free Cash Flow7.76
EV to Operating Cash Flow7.73
Balance Sheet
Jaguar Animal Health has $968.00K in cash and marketable securities with $43.78M in debt, giving a net cash position of -$42.64M billion.
Cash & Marketable Securities$968.00K
Total Debt$43.78M
Net Cash-$42.64M
Net Cash Per Share-$70.70
Tangible Book Value Per Share-$520.84
Margins
Gross margin is ―, with operating margin of -398.82%, and net profit margin of -465.42%.
Gross Margin―
Operating Margin-398.82%
Pretax Margin-469.09%
Net Profit Margin-465.42%
EBITDA Margin-329.18%
EBIT Margin-329.21%
Analyst Forecast
The average price target for Jaguar Animal Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast155.96%
EPS Growth Forecast87.56%